Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography
Molecules · 2023
DOI: 10.3390/molecules28155634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Chen Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jinzhou Medical University, Jinzhou 121001, China. Hauptthemen laut MEDLINE: Prodrugs, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Liaoning province, Education Department of Liaoning Province, China.
Abstract (Originalsprache)
SARS-CoV-2 is a highly contagious and pathogenic virus that first appeared in late December 2019 and caused a global pandemic in a short period. The virus is a single-stranded RNA virus belonging to the Coronaviridae family. Numerous treatments have been developed and tested in response to the pandemic, particularly antiviral drugs. Among them, GS441524 (GS441), a nucleoside antiviral drug, has demonstrated promising results in inhibiting SARS-CoV-2. Nevertheless, the limited oral bioavailability of GS441 restricts its application to patients with the virus. In this study, a novel prodrug of GS441 (NGP-1) with an isobutyl ester and cyclic carbonate structure was designed and synthesized. Its purity and the stability in different artificial digestive juices of NGP-1 was determined with HPLC-DAD methods. The pharmacokinetics of NGP-1 and GS441 were studied in rats via gavage administration. A new LC-MS/MS method was developed to quantitatively analyze GS441 in plasma samples. The results showed that the ka, Cmax, and MRT of converted GS441 from NGP-1 were 5.9, 3, and 2.5 times greater than those of GS441 alone. The Frel of NGP-1 was approximately four-fold that of GS441, with an AUC0–∞ of 9716.3 h·ng mL−1. As a prodrug of GS441, NGP-1 increased its lipophilicity, absorption, and bioavailability, indicating that it holds promise in improving the clinical efficacy of anti-SARS-CoV-2 medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jinzhou Medical University, Jinzhou 121001, China.
- International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Förderung
- Education Department of Liaoning province
- Education Department of Liaoning Province, China
Zitieren
APA
Sun, C., Liu, B., Zhou, F., Zheng, Q., Dai, C., Wei, W., Liao, G., & Sun, Y. (2023). Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography. Molecules. https://doi.org/10.3390/molecules28155634
Vancouver
Sun C, Liu B, Zhou F, Zheng Q, Dai C, Wei W, et al. Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography. Molecules. 2023. doi:10.3390/molecules28155634
BibTeX
@article{Sun2023,
author = {Sun, Chen and Liu, Bo and Zhou, Fengzhi and Zheng, Qianqian and Dai, Chunmei and Wei, Wei and Liao, Guochao and Sun, Yuqi},
title = {Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28155634}
}
EUVIMED